Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)
China
· Delayed Price · Currency is CNY 85.47
-1.03 (-1.19%)
Apr 24, 2025, 2:45 PM CST
SHA:688016 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Operating Revenue | 1,206 | 1,187 | 896.5 | 684.63 | 465.06 | Upgrade
|
| Other Revenue | - | 0.01 | - | - | 5.19 | Upgrade
|
| Revenue | 1,206 | 1,187 | 896.5 | 684.63 | 470.25 | Upgrade
|
| Revenue Growth (YoY) | 1.61% | 32.43% | 30.95% | 45.59% | 40.91% | Upgrade
|
| Cost of Revenue | 325.58 | 285.93 | 224.74 | 154 | 101.72 | Upgrade
|
| Gross Profit | 880.75 | 901.27 | 671.76 | 530.63 | 368.53 | Upgrade
|
| Selling, General & Admin | 250.25 | 185.19 | 150.02 | 103.81 | 77.95 | Upgrade
|
| Research & Development | 93.77 | 172.88 | 137.54 | 102.27 | 73.01 | Upgrade
|
| Other Operating Expenses | -28.3 | 9.85 | 8.3 | 5.32 | 2.8 | Upgrade
|
| Operating Expenses | 315.72 | 369.26 | 298.49 | 212.68 | 154.52 | Upgrade
|
| Operating Income | 565.02 | 532.01 | 373.27 | 317.95 | 214.02 | Upgrade
|
| Interest Expense | - | -1.82 | -2.09 | -1.77 | - | Upgrade
|
| Interest & Investment Income | 87.41 | 18.41 | 15.36 | 28.79 | 22.63 | Upgrade
|
| Currency Exchange Gain (Loss) | - | 1.19 | 2 | -0.44 | -0.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 4.42 | -0.22 | -0.24 | -0.16 | -0.11 | Upgrade
|
| EBT Excluding Unusual Items | 656.86 | 549.58 | 388.29 | 344.38 | 235.63 | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.03 | -0.1 | -0.23 | - | -0.04 | Upgrade
|
| Asset Writedown | -4.69 | - | - | - | - | Upgrade
|
| Other Unusual Items | - | 22.79 | 25.83 | 17.28 | 13.97 | Upgrade
|
| Pretax Income | 652.19 | 572.27 | 413.9 | 361.66 | 249.55 | Upgrade
|
| Income Tax Expense | 159.45 | 85.05 | 61.84 | 48.15 | 34.94 | Upgrade
|
| Earnings From Continuing Operations | 492.75 | 487.22 | 352.05 | 313.51 | 214.61 | Upgrade
|
| Minority Interest in Earnings | 9.35 | 5.21 | 4.83 | 2.34 | - | Upgrade
|
| Net Income | 502.1 | 492.43 | 356.88 | 315.86 | 214.61 | Upgrade
|
| Net Income to Common | 502.1 | 492.43 | 356.88 | 315.86 | 214.61 | Upgrade
|
| Net Income Growth | 1.96% | 37.98% | 12.99% | 47.17% | 51.40% | Upgrade
|
| Shares Outstanding (Basic) | 123 | 108 | 107 | 107 | 107 | Upgrade
|
| Shares Outstanding (Diluted) | 123 | 108 | 107 | 107 | 107 | Upgrade
|
| Shares Change (YoY) | 14.50% | 0.50% | 0.00% | -0.10% | 17.36% | Upgrade
|
| EPS (Basic) | 4.07 | 4.57 | 3.33 | 2.95 | 2.00 | Upgrade
|
| EPS (Diluted) | 4.07 | 4.57 | 3.33 | 2.95 | 2.00 | Upgrade
|
| EPS Growth | -10.95% | 37.30% | 12.99% | 47.32% | 29.01% | Upgrade
|
| Free Cash Flow | 160.95 | 368.05 | 39.78 | 210.67 | 191.22 | Upgrade
|
| Free Cash Flow Per Share | 1.30 | 3.42 | 0.37 | 1.97 | 1.78 | Upgrade
|
| Dividend Per Share | - | 2.013 | 1.544 | 1.409 | 0.604 | Upgrade
|
| Dividend Growth | - | 30.44% | 9.52% | 133.34% | 38.47% | Upgrade
|
| Gross Margin | 73.01% | 75.91% | 74.93% | 77.51% | 78.37% | Upgrade
|
| Operating Margin | 46.84% | 44.81% | 41.64% | 46.44% | 45.51% | Upgrade
|
| Profit Margin | 41.62% | 41.48% | 39.81% | 46.13% | 45.64% | Upgrade
|
| Free Cash Flow Margin | 13.34% | 31.00% | 4.44% | 30.77% | 40.66% | Upgrade
|
| EBITDA | 603.12 | 553.24 | 395.92 | 333.41 | 227.94 | Upgrade
|
| EBITDA Margin | 50.00% | 46.60% | 44.16% | 48.70% | 48.47% | Upgrade
|
| D&A For EBITDA | 38.1 | 21.22 | 22.65 | 15.46 | 13.92 | Upgrade
|
| EBIT | 565.02 | 532.01 | 373.27 | 317.95 | 214.02 | Upgrade
|
| EBIT Margin | 46.84% | 44.81% | 41.64% | 46.44% | 45.51% | Upgrade
|
| Effective Tax Rate | 24.45% | 14.86% | 14.94% | 13.31% | 14.00% | Upgrade
|
| Revenue as Reported | - | 1,187 | 896.5 | 684.63 | 470.25 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.